Samarth Kulkarni | Chief Executive Officer
CRISPR Therapeutics

Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 09:40

Keynote Panel: Advancing cell and gene therapy – considerations in manufacturing, R&D expertise, early payer engagement and continuous patient centricity

Moderator: Sophie Schmitz, Managing Partner, Partners4Access
Sandy Macrae, President And Chief Executive Officer, Sangamo Therapeutics
Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer
Matthew Patterson, President And Chief Executive Officer, Audentes Therapeutics
Mark Rothera, President And Chief Executive Officer, Orchard Therapeutics
Andre Choulika, Chairman And Chief Executive Officer, Cellectis
Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
last published: 14/Mar/19 17:55 GMT

back to speakers